Paragon Care Ltd (ASX: PGC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Paragon Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$662.12 million
P/E Ratio
30.00
Dividend Yield
0.00%
Shares Outstanding
1.66 billion
Earnings per share
0.013
Dividend per share
0.01
Year To Date Return
-21.88%
Earnings Yield
3.33%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Paragon Care Ltd (ASX: PGC)
Latest News
Healthcare Shares
Why I think this ASX small-cap stock is a bargain at 40 cents
Share Market News
2 compelling ASX small-cap shares this fundie expects to beat the market
Share Gainers
Why DroneShield, Healius, Newmont, and Paragon Care shares are pushing higher
Mergers & Acquisitions
Guess which ASX small cap stock is rocketing 27% on 'transformative' merger
Healthcare Shares
ASX dividend stocks: Here's a diamond in the rough I'd buy yielding more than 6%
Earnings Results
Paragon Care (ASX: PGC) share price soars 5% on $8.3 million profit
Share Market News
ASX winners and losers from the Victorian budget
Share Market News
Here's why the Paragon (ASX:PGC) share price has surged 19% today
Healthcare Shares
Why the Paragon Care share price is rocketing 83% today
Share Market News
Why these 3 ASX shares surged higher today
Share Fallers
Why ARB, OneVue, Origin Energy, & Paragon Care are tumbling lower
Share Market News
Why the Paragon share price has plummeted 19% today
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2023 | $0.0060 | 100.00% | Final | 06 Oct 2023 |
| 14 Mar 2023 | $0.0060 | 100.00% | Interim | 05 Apr 2023 |
| 12 Sep 2022 | $0.0060 | 100.00% | Final | 04 Oct 2022 |
| 21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
| 13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
| 21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
| 14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
| 15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
| 09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
| 08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
| 07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
| 04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Paragon Care Ltd
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. Its product categories include balance and mobility, beds, mattresses and furniture, carts and trolleys, consulting room equipment, dermatology and cosmetic medicine, general medical products, consumables, infection control, lighting, materials management, newborn care, operating theatre, and ophthalmic. The company was founded in 1994 and is headquartered in South Melbourne, Australia.
PGC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Jun 2025 | $0.40 | $0.03 | 8.00% | 1,349,512 | $0.38 | $0.40 | $0.36 |
| 10 Jun 2025 | $0.38 | $-0.01 | -2.63% | 332,486 | $0.38 | $0.38 | $0.36 |
| 06 Jun 2025 | $0.38 | $0.00 | 0.00% | 164,298 | $0.38 | $0.38 | $0.37 |
| 05 Jun 2025 | $0.38 | $-0.02 | -5.06% | 1,172,559 | $0.38 | $0.39 | $0.38 |
| 04 Jun 2025 | $0.40 | $0.00 | 0.00% | 306,537 | $0.39 | $0.40 | $0.39 |
| 03 Jun 2025 | $0.40 | $-0.01 | -2.50% | 973,815 | $0.40 | $0.40 | $0.39 |
| 02 Jun 2025 | $0.40 | $0.01 | 2.53% | 466,096 | $0.39 | $0.40 | $0.39 |
| 30 May 2025 | $0.40 | $-0.01 | -2.50% | 763,357 | $0.40 | $0.40 | $0.39 |
| 29 May 2025 | $0.40 | $0.00 | 0.00% | 2,886,319 | $0.40 | $0.41 | $0.39 |
| 28 May 2025 | $0.40 | $0.02 | 5.26% | 707,243 | $0.40 | $0.40 | $0.39 |
| 27 May 2025 | $0.38 | $-0.01 | -2.56% | 204,596 | $0.40 | $0.40 | $0.38 |
| 26 May 2025 | $0.39 | $0.00 | 0.00% | 860,473 | $0.40 | $0.41 | $0.39 |
| 23 May 2025 | $0.39 | $-0.02 | -4.88% | 319,119 | $0.39 | $0.41 | $0.39 |
| 22 May 2025 | $0.41 | $0.00 | 0.00% | 1,624,461 | $0.40 | $0.41 | $0.39 |
| 21 May 2025 | $0.41 | $0.00 | 0.00% | 656,026 | $0.40 | $0.41 | $0.39 |
| 20 May 2025 | $0.41 | $-0.02 | -4.76% | 1,630,433 | $0.43 | $0.43 | $0.40 |
| 19 May 2025 | $0.42 | $-0.01 | -2.35% | 546,570 | $0.42 | $0.42 | $0.40 |
| 16 May 2025 | $0.43 | $0.01 | 2.38% | 976,292 | $0.42 | $0.44 | $0.42 |
| 15 May 2025 | $0.42 | $0.01 | 2.44% | 67,825 | $0.42 | $0.43 | $0.42 |
| 14 May 2025 | $0.41 | $-0.01 | -2.38% | 88,290 | $0.43 | $0.43 | $0.41 |
| 13 May 2025 | $0.42 | $-0.01 | -2.33% | 377,348 | $0.43 | $0.43 | $0.41 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 11 Mar 2025 | Carmen Riley | Buy | 100,000 | $41,000 |
On-market trade.
|
| 02 Dec 2024 | John Walstab | Sell | 14,000,000 | $7,000,000 |
On-market trade.
|
| 27 Nov 2024 | Carmen Riley | Issued | 2,214,267 | $1,096,062 |
Issue of securities. 2,214,267 Performance Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Peter Andre Lacaze | Non-Executive ChairmanNon-Executive Director | Jun 2024 |
Mr Lacaze has been involved in CH2 Holdings since 2006 as a minority shareholder and was the Chief Executive Officer between 2006 to 2008. Peter became the Chairman of CH2 Holdings in December 2015 when David Collins and Peter acquired 100% of CH2 Holdings. As an experienced Australian business leader, Peter has worked in a number of industries with particular emphasis on healthcare and travel. Peter brings a dynamic and practical approach with a long-term lens on driving business performance. He is member of Risk Committee.
|
| Mr Michael Sapountzis | Company Secretary | Nov 2024 |
--
|
| Ms Carmen Rose Riley | Chief Operating OfficerExecutive Director | Jun 2024 |
Ms Riley was appointed Chief Operating Officer in 2017 after transitioning from General Manager of Sales. Before joining CH2 Holdings Carmen was CEO of PQ Lifestyles (Intouch) from July 2008, which was successfully acquired by CH2 Holdings in 2010. Prior to joining the Healthcare industry Carmen had a career within FMCG, including Supply Chain and Operations, Finance and Project Management. Carmen's experience provides strong financial and operational management skills gained from both private and ASX listed companies. She is Chair pf Risk Committee.
|
| Mr David Keith Collins | Chief Executive OfficerManaging Director | Jun 2024 |
Mr Collins was appointed as CEO and Managing Director in December 2015 of CH2 Holdings when David and Peter Lacaze acquired 100% of CH2 Holdings. David has been with CH2 Holdings since 2005 starting as Chief Financial Officer and then moving into the Managing Director role in 2008 until 2014. In 2006 David became a minority shareholder of CH2 Holdings. David spent 14 months as the Chief Financial Officer at Greencross Health Limited in Auckland. David brings experience and knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors.
|
| Mr Peter John Egglestone | Non-Executive Director | Mar 2025 |
Mr Egglestone is a senior executive and has more than 25 years leadership, financial and commercial experience. Peters most recent role was CEO of one of Australias payment facilitators. In addition, Peter has held a number of C-Suite positions including for private equity business Journey Beyond, where he led all revenue functions, including sales, marketing, revenue management and customer relations.Peter has a finance and economics background.
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cherie Maria Millar & David Keith Collins <Collins Millar Family> | 471,762,036 | 28.50% |
| Peter Andre Lacaze & Dianne Maree Lacaze <Lacaze Family> | 471,762,036 | 28.50% |
| Mr John Walstab(i) | 157,956,314 | 9.54% |
| Citicorp Nominees Pty Limited | 83,356,419 | 5.04% |
| HSBC Custody Nominees (Australia) Limited | 72,799,499 | 4.40% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 46,875,287 | 2.83% |
| First Samuel Ltd ACN 086243567 <ANF ITS MDA Clients A/C> | 20,145,625 | 1.22% |
| J P Morgan Nominees Australia Pty Limited | 12,992,454 | 0.78% |
| Certane CT Pty Ltd <Hayborough OPP Fund> | 11,000,000 | 0.66% |
| Phillip Graham Sidney Pty Ltd <Sidney Super Fund A/C> | 8,602,020 | 0.52% |
| Realm Group Pty Limited | 7,520,575 | 0.45% |
| BNP Paribas Noms Pty Ltd | 5,620,955 | 0.34% |
| Negroni Holdings Pty Ltd <The DFN A/C> | 4,727,531 | 0.29% |
| BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> | 4,637,414 | 0.28% |
| Dixson Trust Pty Limited | 4,506,994 | 0.27% |
| Mrs Sandra Joan McDonald & Mr Andrew McDonald <McDonald Family S/Fund A/C> | 4,502,524 | 0.27% |
| JMT Investment Group VIC Pty Ltd <John Turner Super Fund A/C> | 4,500,000 | 0.27% |
| Rathvale Pty Limited | 4,152,250 | 0.25% |
| JMT Investment Group VIC Pty Ltd | 4,000,000 | 0.24% |
| Mr Richard Albarran | 3,942,129 | 0.24% |
| Mr Drew Townsend | 3,942,128 | 0.24% |
